Landauer

LANDAUER is the global leader in radiation science and services. We provide tools and support to organizations with potential exposure to ionizing radiation, helping them achieve their radiation safety goals. Our proprietary, state-of-the-art optically stimulated luminescence (OSL) technology enables the most precise measurements possible for occupational radiation monitoring and environmental monitoring and a full range of specialized applications including machine quality assurance and patient radiation monitoring. We back our advanced technology with the most flexible dosimetry programs and best customer service the industry has to offer. While technology continues to advance, one thing is certain with each innovation we must also focus on identifying and mitigating any potential risks related to the benefits. As the first organization to recognize and address radiation risks, and with a sustained history of innovation and dedication unequaled in the industry, LANDAUER is uniquely poised to lead this quest for improved personal and public health and safety across the globe.
Type
Public
HQ
Glenwood, US
Founded
1954
Size (employees)
600 (est)
Landauer was founded in 1954 and is headquartered in Glenwood, US

Landauer Office Locations

Landauer has an office in Glenwood
Glenwood, US (HQ)
2 Science Rd

Landauer Data and Metrics

Landauer Financial Metrics

Landauer's revenue was reported to be $149.2 m in FY, 2016 which is a 1% decrease from the previous period.
USD

Revenue (FY, 2016)

149.2 m

Revenue growth (FY, 2015 - FY, 2016), %

(1%)

Gross profit (FY, 2016)

75.5 m

Gross profit margin (FY, 2016), %

51%

Net income (FY, 2016)

18.5 m

EBIT (FY, 2016)

26.6 m

Market capitalization (22-Jun-2017)

513.8 m

Closing share price (22-Jun-2017)

52.6

Cash (31-Dec-2016)

13.3 m

EV

609.6 m
Landauer's current market capitalization is $513.8 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

150.2 m155.1 m151.3 m149.2 m

Revenue growth, %

3%(2%)(1%)

Cost of goods sold

71.1 m17.9 m72.6 m73.8 m

Gross profit

79.1 m137.1 m78.7 m75.5 m

Gross profit Margin, %

53%88%52%51%

EBIT

3.4 m(40 m)23.7 m26.6 m

EBIT margin, %

2%(26%)16%18%

Net Income

2.8 m(25.2 m)15 m18.5 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

11.2 m6.8 m15.3 m13.3 m

Inventories

9.5 m6.7 m7 m5.7 m

Current Assets

63 m54.3 m61.8 m56 m

Goodwill

84.4 m43.2 m35.1 m33.8 m

Total Assets

274.7 m216.6 m208.7 m190.8 m

Accounts Payable

6.3 m6.2 m5.8 m3 m

Dividends Payable

5.4 m5.3 m2.7 m2.8 m

Total Debt

142.8 m133.6 m133.4 m109.1 m

Current Liabilities

42.5 m44.7 m38.5 m34.5 m

Non-Current Liabilities

166.6 m158.1 m157.9 m135.7 m

Total Liabilities

209 m202.9 m196.4 m170.2 m

Additional Paid-in Capital

39.5 m40.3 m41.5 m44 m

Retained Earnings

32 m(18.9 m)(17.6 m)(10.5 m)

Total Equity

65 m13.7 m12.3 m20.6 m

Debt to Equity Ratio

2.2 x9.7 x10.8 x5.3 x

Debt to Assets Ratio

0.5 x0.6 x0.6 x0.6 x

Financial Leverage

4.2 x15.8 x16.9 x9.3 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

5.7 m(24.7 m)15 m18.5 m

Depreciation and Amortization

14.9 m13.9 m12.3 m11.1 m

Cash From Operating Activities

23 m36.7 m28.3 m31.5 m

Purchases of PP&E

(9.1 m)(4.2 m)(8 m)(8.9 m)

Cash From Investing Activities

(8.5 m)(7.2 m)(2.3 m)1.8 m

Cash From Financing Activities

(20.7 m)(30.9 m)(16.5 m)(35.3 m)

Income Taxes Paid

7.4 m6.7 m6.7 m1.7 m
Y, 2016

EV/EBIT

22.9 x

EV/CFO

19.3 x

Debt/Equity

5.3 x

Debt/Assets

0.6 x

Financial Leverage

9.3 x

Landauer Operating Metrics

Landauer's Customers was reported to be 73 k in Q1, 2017
Q1, 2017

Customers

73 k

Patients Served per Year

1.8 m

Landauer Market Value History

Landauer Revenue Breakdown

Landauer Company Life and Culture

You may also be interested in